TD Waterhouse Canada Inc. Invests $795,000 in Cabot Co. (NYSE:CBT)

TD Waterhouse Canada Inc. acquired a new position in shares of Cabot Co. (NYSE:CBT - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 8,705 shares of the specialty chemicals company's stock, valued at approximately $795,000.

Several other institutional investors have also recently added to or reduced their stakes in the company. GAMMA Investing LLC increased its stake in shares of Cabot by 10.7% during the 4th quarter. GAMMA Investing LLC now owns 1,348 shares of the specialty chemicals company's stock valued at $123,000 after acquiring an additional 130 shares during the last quarter. Personal CFO Solutions LLC increased its position in Cabot by 3.3% during the fourth quarter. Personal CFO Solutions LLC now owns 4,285 shares of the specialty chemicals company's stock worth $391,000 after purchasing an additional 137 shares during the last quarter. Isthmus Partners LLC raised its stake in Cabot by 4.8% during the fourth quarter. Isthmus Partners LLC now owns 4,072 shares of the specialty chemicals company's stock worth $372,000 after purchasing an additional 187 shares during the period. Neuberger Berman Group LLC boosted its holdings in shares of Cabot by 1.2% in the 4th quarter. Neuberger Berman Group LLC now owns 18,238 shares of the specialty chemicals company's stock valued at $1,665,000 after purchasing an additional 212 shares during the last quarter. Finally, EverSource Wealth Advisors LLC boosted its holdings in shares of Cabot by 37.2% in the 4th quarter. EverSource Wealth Advisors LLC now owns 808 shares of the specialty chemicals company's stock valued at $74,000 after purchasing an additional 219 shares during the last quarter. Institutional investors and hedge funds own 93.18% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the company. Mizuho cut their target price on Cabot from $122.00 to $110.00 and set an "outperform" rating on the stock in a research report on Tuesday, January 7th. JPMorgan Chase & Co. decreased their target price on Cabot from $105.00 to $85.00 and set an "underweight" rating for the company in a report on Friday, February 21st. UBS Group cut their price target on shares of Cabot from $93.00 to $83.00 and set a "neutral" rating on the stock in a report on Monday, April 7th. Finally, StockNews.com raised shares of Cabot from a "hold" rating to a "buy" rating in a research note on Thursday, April 17th.

Cabot Stock Down 0.9 %

Shares of Cabot stock traded down $0.68 during trading hours on Wednesday, hitting $78.04. 57,944 shares of the company's stock traded hands, compared to its average volume of 390,808. Cabot Co. has a twelve month low of $73.63 and a twelve month high of $117.46. The stock has a 50 day simple moving average of $81.60 and a 200-day simple moving average of $93.24. The company has a quick ratio of 1.29, a current ratio of 2.00 and a debt-to-equity ratio of 0.72. The company has a market cap of $4.23 billion, a PE ratio of 10.35, a PEG ratio of 0.74 and a beta of 1.04.

Cabot (NYSE:CBT - Get Free Report) last released its earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 EPS for the quarter, beating the consensus estimate of $1.74 by $0.02. Cabot had a return on equity of 26.79% and a net margin of 10.60%. Equities research analysts anticipate that Cabot Co. will post 7.57 earnings per share for the current fiscal year.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.